Chapter 2: The Archive of the Ghost
Chapter 2: The Archive of the Ghost
The private wing of Boston Children’s Hospital was silent, illuminated only by the soft, green glow of the patient monitors and the distant, amber lights of the city skyline outside the window. Lily was fast asleep in a large, comfortable bed, her breathing now deep and rhythmic, her face resting against a fresh white pillowcase. The pink coat had been washed, and a tray of untouched food sat on the bedside table, waiting for her to wake up.
Grace was curled up in the leather armchair beside the bed, an oversized mug of tea between her hands. She had changed into a clean, simple sweatshirt that Marcus had purchased from the hospital gift shop, but her eyes were still shadowed by the lingering ghost of her trauma.
Brennan stood by the window, his coat removed, his shirtsleeves rolled up to his forearms. He had spent the last three hours on his phone, ignoring forty-seven urgent messages from his executive board, his CFO, and his legal compliance team. They were frantic. The regulatory meeting had collapsed in his absence, and rumors were already starting to circulate that the CEO of Ashford Global had suffered a personal crisis.
"She looks better," Brennan said quietly, breaking the silence without turning around.
"The doctor said her lungs are clearing up faster than they expected," Grace whispered, looking at her daughter. "That medication... RespiCure. It’s like a miracle. Within twenty minutes of the first dose, her oxygen levels went back up to ninety-eight percent. I’ve spent six months trying to get her that specific inhaler, Mr. Ashford. Every clinic I went to told me the same thing: without the platinum insurance tier or four hundred dollars in cash, their hands were tied."
Brennan turned to face her, his hands tucked into his pockets. "Do you know who manufactures that drug, Grace?"
Grace shook her head slowly. "No. I just know it has a little silver leaf logo on the box."
"That silver leaf is the crest of my family's estate," Brennan said, his voice flat and bitter. "My father designed it. My company owns the patent. We produce that medication for less than four dollars a unit in our facility in New Jersey. We sell it to the distributors for three hundred and eighty."
Grace stared at him, her hands tightening around her mug. The warmth in her eyes instantly vanished, replaced by a cold, sudden realization that made her pull back slightly into the chair. "You... your family makes it? Then why... why is it so hard for people like us to get it? If it costs so little to make, why did my daughter have to sleep on a concrete floor because I couldn't afford to buy her the right to breathe?"
"Because my father believed that human suffering was the most reliable market index in the world," Brennan said, the truth tasting like ash in his mouth. "He used to tell me that if you make a luxury car too expensive, people buy a cheaper one. But if you make a life-saving medicine expensive, people will sell their homes, their cars, and their souls to buy it because they have no other choice. That’s how you build an eleven-billion-dollar dynasty, Grace. You find the things people cannot live without, and you put a lock on the door."
He walked over to the small table in the corner of the room and opened his laptop. For the past hour, he had been navigating through the encrypted internal archives of Ashford Global, searching for something he hadn't thought about in over a decade—a specific research project that had been abruptly terminated by his father just weeks before his death.
"When I was twenty-five, I started as a junior analyst in our research and development wing," Brennan said, his eyes fixed on the screen as the progress bar crept toward one hundred percent. "I found a file about an experimental outreach program called 'Project Breathless.' It was supposed to be a philanthropic initiative designed to distribute RespiCure-DX directly to low-income communities and public shelters at cost. It was fully funded, fully approved by the clinical trial boards, and then... overnight, it was erased from our corporate filings. My father told me it was cancelled due to 'distribution logistics.' I believed him."
He tapped a key, opening a hidden directory that had required his personal biometric bypass to access.
"But look at this," Brennan whispered, turning the laptop screen toward Grace.
The document displayed an internal memorandum from December 2022, signed with the unmistakable, bold script of Montgomery Ashford. The subject line read: Risk Assessment regarding Project Breathless and the Miller Sub-Trial.
Grace's breath caught in her throat when she saw the name. "Miller? That’s... that’s my husband’s name. David Miller."
"Your husband?" Brennan stepped closer, his heart starting to beat with a strange, erratic rhythm. "Grace, what did your husband do?"
"He was a chemical technician," she said, her voice dropping into a hollow, haunted whisper. "He worked for an independent testing laboratory here in Boston. Three years ago, he was hired to do a third-party compliance review on a new batch of respiratory compounds for a major pharmaceutical firm. He never told me the name of the company—he said it was under a strict non-disclosure agreement. But one night, he came home terrified. He said he had found a major anomaly in the baseline data. He said the company was intentionally suppressing a secondary development pathway—a pathway that would have made the drug a permanent cure for pediatric asthma, rather than a temporary treatment that required a lifelong prescription."
Brennan felt the room spin slightly. He looked back at the screen, his eyes scanning the technical data attached to his father's memo. The chemical equations were complex, but the executive summary was clear: The continuous-use formulation provides a projected lifetime value of $42,000 per patient. The single-course eradication protocol reduces total market capitalization by eighty-four percent over a five-year projection. Project Breathless is to be terminated immediately. All third-party samples are to be recovered or neutralized.
"David died two weeks later," Grace whispered, a single tear spilling over her lower lid. "They said it was a single-vehicle accident on the Massachusetts Turnpike. He lost control of his car on the ice. When the police gave me his personal belongings, his laptop was missing. His phone had been completely smashed. A month after that, our landlord raised our rent by eighty percent, and when I tried to look for work, every laboratory in the city refused to even take my resume. It was like someone had put a black mark next to my name in every system in the state."
May you like
Brennan sank into the chair opposite her, his hands trembling as he stared at the screen. The truth was worse than anything he had imagined. His father hadn't just been a cold, calculating businessman; he had been a monster who had systematically ruined a family to protect a profit margin, hiding a cure behind a wall of manufactured scarcity while the child of the man who discovered it suffocated on the floor of a transit station.
"He didn't just ignore the poor, Grace," Brennan said, his voice shaking with a profound, terrifying anger. "He created them. He broke your family to protect his balance sheet. And for thirty-seven years, I sat in his boardrooms and thought he was a genius."
